# Study of Teclistamab in Combination in Elderly Patients With Multiple Myeloma

> **NCT05572229** · PHASE2 · RECRUITING · sponsor: **University Hospital, Lille** · enrollment: 74 (estimated)

## Conditions studied

- Multiple Myeloma

## Interventions

- **DRUG:** Teclistamab
- **DRUG:** Daratumumab
- **DRUG:** Lenalidomide

## Key facts

- **NCT ID:** NCT05572229
- **Lead sponsor:** University Hospital, Lille
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2023-12-21
- **Primary completion:** 2026-04
- **Final completion:** 2030-09
- **Target enrollment:** 74 (ESTIMATED)
- **Last updated:** 2025-09-17

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05572229

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05572229, "Study of Teclistamab in Combination in Elderly Patients With Multiple Myeloma". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT05572229. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*